Champix
The European Commission approved Champix on September 29th, 2006 as a "stop smoking" aid for adults, based on the results from clinical trials. It should be noted that continued abstinence from cigarettes is higher (70% compared with 50%) when patients take the drug for 24 weeks as opposed to 12, so it may be appropriate for patients who have succeeded in quitting smoking at the 12 week point to take the drug for a further 12 weeks.
More information about Champix